血清CA19-9异常增高胆总管结石7例诊治体 会.pdfVIP

Hans Journal of Surgery 外科, 2017, 6(1), 8-12 Published Online January 2017 in Hans. /journal/hjs /10.12677/hjs.2017.61002 Experience of Diagnosis and Treatment of 7 Cases of Common Bile Duct Stones with Abnormal Increase of Serum CA19-9 * Limin Liu, Zongming Zhang , Zhuo Liu, Chong Zhang, Hongwei Yu, Zixu Liu, Mingwen Zhu, Mengmeng Song, Yue Zhao Department of General Surgery, Beijing Electric Power Hospital, Capital Medical University, Beijing st th th Received: Dec. 21 , 2016; accepted: Jan. 7 , 2017; published: Jan. 10 , 2017 Copyright © 2017 by authors and Hans Publishers Inc. This work is licensed under the Creative Commons Attribution International License (CC BY). /licenses/by/4.0/ Open Access Abstract Serum CA19-9 is one of the most common tumor markers whose elevation is common in patients with various malignant tumors of digestive system, especially bile duct carcinoma, pancreatic cancer, which has important reference value in the differential diagnosis of benign and malignant biliary diseases. Patients with benign biliary tract disease, abnormal elevated serum CA19-9 are rare. Based on our experience of abnormal increase of serum CA19-9 in 7 patients with choledo- cholithiasis, this paper will further investigate the etiology, diagnosis and treatment of bile duct stones in patients with abnormal serum CA19-9 increased, so as to effectively improve the diagno- sis and treatment effect of the biliary tract benign disease patients with abnormal elevated serum CA19-9, and to avoid misdiagnosis and mistreatment of biliary tract malignant tumor. Keywords Common Bile Duct Stones, Acute Cholangitis, Serum CA19-9 血清CA19-9